Edibles, often seen through the lens of recreational use, possess a wide net of health benefits that are garnering attention from the medical community. While smoking cannabis remains a popular method of consumption, edibles offer a discreet, smoke-free alternative that can provide significant therapeutic advantages.
My journey into understanding the benefits of cannabis edibles began with a personal interest. The consumption of cannabis edibles can be quite different from other forms of cannabis consumption, such as smoking or vaping. Edibles provide a strong “body high” that can feel like a deep relaxation or relief from tension within. I started to notice how it helps with chronic pain after I started to divulge into the topic.
Traditional medications offered little relief, and side effects were often debilitating. Cannabis was initially met with skepticism but eventually with profound appreciation for their therapeutic potential. One of the most prominent benefits of cannabis edibles is its effectiveness in pain management.
Edibles, particularly those infused with cannabinoids like THC and CBD, offer sustained relief for chronic pain for conditions such as neuropathy, arthritis, or fibromyalgia. The digestion process allows for a slow release of cannabinoids, leading to prolonged effects that help such patients manage the pain throughout the day. Research has proven and accepted that cannabinoids can reduce pain and improve quality of life in patients with chronic pain conditions.
Other than pain management, it plays a crucial role in sleep aids, stress management, and gastrointestinal disorders too. The cannabinoids interact with the anxiolytic properties in the body, regulating mood and promoting a sense of calmness. Unlike inhalation, edibles provide a gradual onset of effects that help avoid the sudden spikes in anxiety that people can experience with smoking or vaping.
On the other spectrum, THC-infused edibles are shown to help induce sleep and improve sleep quality. Consuming edibles an hour or two before bedtime allows patients to benefit from the prolonged effect to help them stay asleep longer and potentially well rested by morning. Edibles can aid individuals with Crohn’s disease or patient’s undergoing chemotherapy. Individuals with GI conditions or undergoing chemotherapy often experience loss of appetite or inflammation within the GI tracts. Cannabinoids possess anti-inflammatory properties that can help reduce inflammation and pain in the digestive tract. Alongside stimulates appetite to help patients maintain a healthy weight and prevent malnutrition or weight loss. The effects of edibles tend to last several hours, providing a window of relief where patients can ear more comfortably.
Emerging research suggests that cannabinoids could have neuroprotective properties that can benefit patients with neurological disorders like Parkinson’s, Alzheimer’s, multiple sclerosis, or seizures. It is believed that edibles can deliver these cannabinoids to support brain health by potentially slowing down disease progression and improving symptoms such as spasms and tremors. The research is currently ongoing, but it has highlighted the potential effects of cannabinoids in various neurodegenerative diseases.
While cannabis edibles offer numerous health benefits, they also come with several potential drawbacks that users and medical professionals should be aware of. Edibles provided a delayed onset, which can lead to overconsumption before the initial dose is felt, leading to an excessively strong and uncomfortable high once the effects do kick in. Unlike smoking or vaping, edible effects can take anywhere from 30 minutes to 2 hours for it to start its effects. Overconsumption can lead to severe intoxication, anxiety, paranoia, and other negative effects.
The risk of acute psychosis or exacerbating symptoms is bound to occur within predisposition individuals with disorders like schizophrenia. Cannabis can interact with other medications, potentially altering their effectiveness or leading to adverse reactions. The concentration of THC and other cannabinoids within homemade or poorly regulated commercial edibles can be inconsistent, leading to unpredictable effects. Hence, patients must consult with healthcare providers before combining cannabis with other prescribed drugs.
Cannabis edibles, once regulated to the realm of recreational use, are providing a potent ally in the field of medical treatment. Their ability to provide sustained relief from pain, anxiety, sleep disorders, appetite loss, and other concerns underscores their therapeutic potential. While it is a promising alternative, it’s essential to approach them with caution due to the potential risks. Understanding these drawbacks can help users make informed decisions and encourage the development of better regulations and guidelines. As research continues to unveil the full spectrum of benefits, edibles are poised to become a cornerstone arsenal of medical cannabis treatment.
The experience of edibles will always vary from one individual to the next and depend on numerous factors. It is important to approach them with caution, awareness, and, most importantly, fun. While respecting the potency and duration of their effects. When used responsibly, edibles can continue to provide a unique and enjoyable way to experience the benefits of cannabis.
References
- Lynch, M. E. & Campbell, F. (2011). Cannabinoids for treatment of chronic non-cancer pain: a systematic review of randomized trials. British Journal of Clinical Pharmacology, 72(5), 735-744
- Freeman, T. P. & Winstock, A. R. (2015). Examining the profile of high-potency cannabis and its association with severity of cannabis dependence. Psychological Medicine, 45(15), 3181-3189
- Shannon, S. (2019). Cannabidiol in anxiety and sleep: a large case series. The Permanente Journal, 23, 18-041
- Aso, E., & Ferrer, I. (2014). Cannabinoids for treatment of Alzheimer’s disease: moving toward the clinic. Frontiers in Pharmacology, 5, 37
- García, C., Palomo-Garo, C., García-Arencibia, M., Ramos, J. A., & Pertwee, R. G. (2011). Symptom-relieving and neuroprotective effects of the phytocannabinoid Δ9-THCV in animal models of Parkinson’s disease
- Vandrey, R., Herrmann, E. S., Mitchell, J. M., Bigelow, G. E., & Flegel, R. (2017). Pharmacokinetic profile of oral cannabis in humans: blood and oral fluid disposition and relation to pharmacodynamic outcomes. Journal of Analytical Toxicology, 41(2), 83-99.
- Grotenhermen, F. (2003). Pharmacokinetics and pharmacodynamics of cannabinoids. Clinical Pharmacokinetics, 42(4), 327-360.
